Changes in sputum viscoelastic properties and airway inflammation in primary ciliary dyskinesia are comparable to cystic fibrosis on elexacaftor/tezacaftor/ivacaftor therapy
European Respiratory Journal · 2026-02 · 67 (2) · 2500616
DOI: 10.1183/13993003.00616-2025 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift European Respiratory Journal, online erschienen am 18.09.2025. Verfasst von Hannah Nussstein und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie …. Hauptthemen laut MEDLINE: Cystic Fibrosis, Sputum, Aminophenols, Benzodioxoles. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Alliance4Rare, Else Kröner-Fresenius-Stiftung, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Background
Primary ciliary dyskinesia (PCD) and cystic fibrosis (CF) are muco-obstructive lung diseases that are caused by distinct genetically determined defects in mucociliary clearance; however, knowledge on the relative severity of airway mucus dysfunction and chronic inflammation remains limited. The aim of this study was therefore to compare sputum viscoelastic properties, inflammation markers and the proteome between patients with PCD and patients with CF before and under elexacaftor/tezacaftor/ivacaftor (ETI) therapy.
Methods
We compared sputum rheology, inflammation markers and the proteome in 42 clinically stable adolescent and adult patients with PCD, 40 patients with CF with at least one F508del allele before (baseline) and 3 months after initiation of ETI, and 15 age-matched healthy controls.
Results
The elastic modulus ( G ′) and viscous modulus ( G ″) of PCD sputum was increased compared to healthy controls (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
- German Center for Lung Research (DZL), associated partner site Berlin, Berlin, Germany.
- German Center for Child and Adolescent Health (DZKJ), partner site Berlin, Berlin, Germany.
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
- Proteomics Platform, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
- Institute for Chemistry and Biochemistry, Freie Universität Berlin, Berlin, Germany.
ORCID-Profile: Kerstin Fentker, Julia Duerr, Mirjam Stahl, Simon Y Graeber, Jobst Röhmel, Marcus A Mall
Förderung
- Alliance4Rare
- Else Kröner-Fresenius-Stiftung
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
Zitieren
APA
Nussstein, H., Urbantat, R. M., Fentker, K., Loewe, A., Duerr, J., Haji, M., Doellinger, F., Stahl, M., Graeber, S. Y., Gradzielski, M., Röhmel, J., Mertins, P., Schaupp, L., & Mall, M. A. (2026). Changes in sputum viscoelastic properties and airway inflammation in primary ciliary dyskinesia are comparable to cystic fibrosis on elexacaftor/tezacaftor/ivacaftor therapy. European Respiratory Journal, 67(2), 2500616. https://doi.org/10.1183/13993003.00616-2025
Vancouver
Nussstein H, Urbantat RM, Fentker K, Loewe A, Duerr J, Haji M, et al. Changes in sputum viscoelastic properties and airway inflammation in primary ciliary dyskinesia are comparable to cystic fibrosis on elexacaftor/tezacaftor/ivacaftor therapy. European Respiratory Journal. 2026;67(2):2500616. doi:10.1183/13993003.00616-2025
BibTeX
@article{Nussstein2026,
author = {Nussstein, Hannah and Urbantat, Ruth M and Fentker, Kerstin and Loewe, Aditi and Duerr, Julia and Haji, Mohamed and Doellinger, Felix and Stahl, Mirjam and Graeber, Simon Y and Gradzielski, Michael and Röhmel, Jobst and Mertins, Philipp and Schaupp, Laura and Mall, Marcus A},
title = {Changes in sputum viscoelastic properties and airway inflammation in primary ciliary dyskinesia are comparable to cystic fibrosis on elexacaftor/tezacaftor/ivacaftor therapy},
journal = {European Respiratory Journal},
year = {2026},
volume = {67},
number = {2},
pages = {2500616},
doi = {10.1183/13993003.00616-2025}
}
EUVIMED